Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Rubella
2022
2004
Europe
Clear all
Type of publications
NITAG documentation
(31)
Systematic reviews (SYSVAC)
(8)
Topics
Available to download in languages
Regions
Europe
(39)
Africa
(24)
Americas
(47)
Eastern Mediterranean
(3)
South-East Asia
(3)
Western Pacific
(21)
Countries
Belgium
(6)
France
(9)
Germany
(2)
Ireland
(5)
Italy
(1)
Luxembourg
(1)
Netherlands
(1)
Spain
(1)
Ukraine
(1)
United Kingdom
(8)
Diseases
COVID-19
(34)
Human papillomavirus (HPV)
(4)
Rubella
(1)
Herpes zoster
(3)
Influenza
(5)
Meningococcal disease
(1)
Mpox // Monkeypox
(8)
Pertussis
(2)
Pneumococcal disease
(3)
Rabies
(1)
Rotavirus
(2)
Vaccine topics
Acceptance
(4)
Coverage
(4)
Ethical issues
(4)
Target population
Adolescents
(1)
Adults
(1)
All age groups
(6)
Children
(2)
Healthcare workers
(3)
Newborn
(2)
Older adults
(1)
Parents/caregivers
(2)
Pregnant women
(1)
Travellers
(1)
Publication date
2022
(38)
2004
(1)
2024
(1)
2023
(15)
2021
(77)
2020
(21)
2019
(9)
2018
(7)
2017
(12)
2016
(4)
2015
(4)
2014
(7)
2013
(3)
2012
(1)
2011
(2)
2010
(5)
2009
(2)
2008
(2)
2007
(3)
39 results found
2022
∙
NIAC
Medium term strategy for the COVID-19 vaccination programme
2022
∙
NIAC
NIAC recommendations for COVID-19 booster vaccination of those aged 12- 15 years
2022
∙
NIAC
NIAC Updated recommendation for HPV vaccination
2022
∙
STIKO
Scientific justification of the STIKO for the recommendation of the 2nd COVID-19 booster vaccination with an mRNA vaccine for groups of people who are particularly at risk of health or are exposed
2022
Second booster vaccination against COVID-19
2022
∙
STIKO
STIKO resolution on the 17th update of the COVID-19 vaccination recommendation
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19 - Place of the NUVAXOVID vaccine (NVX-CoV2373)
2022
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 – Anticipation of potential scenarios in the fall of 2022 in France
2004
Recommendation for Women of Childbearing age on the Contraception Period after Receiving a Rubella-containing vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register